Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-25-000939
Filing Date
2025-04-02
Accepted
2025-04-02 16:30:37
Documents
10

Document Format Files

Seq Description Document Type Size
1 dfan14a14390002_04022025.htm DFAN14A 19310
2 GRAPHIC image_001.jpg GRAPHIC 83095
3 GRAPHIC image_002.jpg GRAPHIC 45065
4 GRAPHIC image_003.jpg GRAPHIC 120171
5 GRAPHIC image_004.jpg GRAPHIC 65511
6 GRAPHIC image_005.jpg GRAPHIC 99001
7 GRAPHIC image_006.jpg GRAPHIC 56595
8 GRAPHIC image_007.jpg GRAPHIC 36350
9 GRAPHIC image_008.jpg GRAPHIC 112786
10 GRAPHIC image_009.jpg GRAPHIC 151501
  Complete submission text file 0000921895-25-000939.txt   1082586
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709 248-681-9815
Opus Genetics, Inc. (Subject) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-34079 | Film No.: 25805220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Sooch Mina (Filed by) CIK: 0001674006 (see all company filings)

Type: DFAN14A